Leal Therapeutics announces leadership changes

Leal Therapeutics, a biotechnology firm focused on developing neuro-metabolic therapeutics, has announced significant updates regarding its executive leadership. The company has appointed new key personnel to its leadership team, signaling a strategic shift or expansion in its operational direction. These appointments are part of a broader business update provided by Leal Therapeutics. The changes are expected to influence the company's ongoing research and development efforts in the challenging field of neuro-metabolic treatments.